Font Size:
a
A
A
Keyword [Second-line Treatment]
Result: 61 - 72 | Page: 4 of 4
61.
Observation Of Clinical Efficacy Of Toripalimab Based Combination Therapy As Second-line In Esophageal Squamous Cell Carcinoma
62.
Second-line Treatment And Pathogenesis Of Primary Biliary Cholangitis And Overlapp Syndrome
63.
A Real World Study Of Second-line Chemotherapy For Advanced Small Intestinal Adenocarcinoma
64.
Single-Center Retrospective Study Of Case Series On Efficacy Of First-Line And Second-Line Treatment For Chronic Graft-Versus-Host Disease
65.
Comparison Of The Efficacy And Safety Of ICIs With Rh-endostatin Versus ICIs With Chemotherapy For The Second-line Treatment Of Advanced NSCLC
66.
Efficacy And Safety Analysis Of Apatinib Combined With Immune Checkpoint Inhibitors And Chemotherapy In Second Line Treatment Of Advanced Cholangiocarcinoma
67.
Comparison Of Efficacy And Safety Of Regorafenib With Or Without PD-1 Inhibitors In The Second-line Treatment Of Advanced Hepatocellular Carcinoma
68.
Efficacy And Safety Of Anlotinib Combined With Docetaxel In Second-line Treatment Of Extensive Small Cell Lung Cancer
69.
Evaluation Of Therapeutic Effect And Survival Analysis Of Fuzheng Jiedu Heluo Therapy In The Treatment Of Advanced Lung Squamous Cell Carcinoma
70.
Retrospective Analysis On The Clinical Significance Of PD-1 Inhibitor In The Second-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma In The Real World
71.
Short-term Clinical Observation And Meta Analysis Of Efficacy And Safety Of PD-1 Inhibitor Combined With Anlotinib In Second-line Treatment Of Advanced Esophageal Squamous Cell Carcinoma
72.
A Clinical Study Of Anrotinib Hydrochloride Combined With Aidi Injection In Patients With Advanced Or Recurrent Non-small Cell Lung After Second-line Treatment
<<First
<Prev
Next>
Last>>
Jump to